2008, Number 4
<< Back
Arch Cardiol Mex 2008; 78 (4)
Value of the assessment of myocardial viability: evaluation with positron emission tomography 18F-FDG
Alexánderson RE, Lamothe MPA, Iñarra TF, Calleja TR, Martínez GA, Ochoa LJM, Meave GA
Language: Spanish
References: 11
Page: 431-437
PDF size: 344.70 Kb.
ABSTRACT
It used to be thought that the consequences of coronary artery disease were final, and that the prognosis of the patient was limited to the extent of the ventricular dysfunction. This paradigm changed radically when the concept of hibernating myocardium was introduced, which states the existence of tissue that can regain contractile function after being re-vascularized. This introduced a new concept in cardiology: myocardial viability. This work presents a clear example of the importance of detecting myocardial viability in selected patients, due to the impact not only in treatment but in prognosis as well. It is also emphasized that positron emission tomography (PET) is the gold standard method to detect myocardial viability.
REFERENCES
Alexánderson E, Ricalde A, Meave A: Viabilidad miocárdica, su importancia en la decisión terapéutica. Arch Cardiol Mex 2005; 75: 13-22.
Rahimtoola SH: The hibernating myocardium. Am Heart J 1989; 117: 211-21.
Wijns W, Vatner S, Camici P: Hibernating Myocardium. N Engl J Med 1998; 339 (3): 173-81.
Fitzgerald J, Parker A, Danias P: F-18 fluorodeoxyglucose SPECT for assessment of myocardial viability. J Nucl Cardiol 2000; 7(4): 382-7.
Bounous EP, Mark DB, Pollock BG: Surgical survival benefits for coronary disease patients with left ventricular dysfunction. Circulation1998; 78: 151-57.
Armstrong Wf, Bossone E: Evaluation of myocardial viability using stress echocardiography. Prog Cardiovasc Dis 1997; 39: 555-66.
Schelbert HR: Metabolic imaging to assess myocardial viability. J Nucl Med 1994; 35: 8S.
Stillman Ae, Wilke N, Jerosch-Herold M: Myocardial Viability. Radiol Clin North Am 1999; 37(2): 361-78.
Alexanderson E, Kerik N, Unzek S, Fermon S: Principios y aplicaciones de la tomografía poremisión de positrones (PET) en la cardiología. PET en México: una realidad. Arch Cardiol Mex 2002; 72: 157-64.
Bax JJ, Veening MA, Visser FC, Van Lingen A, Heine RJ, Comel JH, Visser CA: Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging; a comparative study using different protocols. Eur J Nucl Med. 1997; 24(1): 35-41.
Alexánderson E, Ricalde A, Zerón J, Talayero JA, Cruz P, Adame G, Mendoza G, Meave A: El patrón discordante, representación visual de viabilidad miocárdica con PET. Arch Cardiol Mex 2006; 76: 347-54.
Full text